124 related articles for article (PubMed ID: 23032518)
1. Antitumor effects and preliminary systemic toxicity of ANISpm in vivo and in vitro.
Li M; Li Q; Zhang YH; Tian ZY; Ma HX; Zhao J; Xie SQ; Wang CJ
Anticancer Drugs; 2013 Jan; 24(1):32-42. PubMed ID: 23032518
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of substituted naphthalimides to polyamines as cytotoxic agents targeting the Akt/mTOR signal pathway.
Tian ZY; Xie SQ; Mei ZH; Zhao J; Gao WY; Wang CJ
Org Biomol Chem; 2009 Nov; 7(22):4651-60. PubMed ID: 19865701
[TBL] [Abstract][Full Text] [Related]
3. [Acetylsalicylic acid strengthens the effects of ANISpm against hepatocellular carcinoma and its molecular mechanism].
Xie SQ; Zhang LL; Yang T; Ma Y; Zhang YH; Li Q; Wang JH; Zhao J; Wang CJ
Yao Xue Xue Bao; 2011 Sep; 46(9):1045-50. PubMed ID: 22121773
[TBL] [Abstract][Full Text] [Related]
4. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.
Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ
Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
6. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma.
Lee JH; Lee H; Yun SM; Jung KH; Jeong Y; Yan HH; Hong S; Hong SS
Cancer Lett; 2013 Feb; 329(1):99-108. PubMed ID: 23142281
[TBL] [Abstract][Full Text] [Related]
7. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
[TBL] [Abstract][Full Text] [Related]
8. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
9. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
10. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents.
Tian ZY; Xie SQ; Du YW; Ma YF; Zhao J; Gao WY; Wang CJ
Eur J Med Chem; 2009 Jan; 44(1):393-9. PubMed ID: 18423800
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
Fang EF; Zhang CZ; Zhang L; Fong WP; Ng TB
Int J Biochem Cell Biol; 2012 Aug; 44(8):1351-60. PubMed ID: 22554586
[TBL] [Abstract][Full Text] [Related]
13. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
[TBL] [Abstract][Full Text] [Related]
14. The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo.
Fang EF; Zhang CZ; Wong JH; Shen JY; Li CH; Ng TB
Cancer Lett; 2012 Nov; 324(1):66-74. PubMed ID: 22579806
[TBL] [Abstract][Full Text] [Related]
15. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo.
Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP
Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of interferon-β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation.
Ethiraj P; Veerappan K; Samuel S; Sivapatham S
Fundam Clin Pharmacol; 2015 Jun; 29(3):278-85. PubMed ID: 25773664
[TBL] [Abstract][Full Text] [Related]
17. The selective Hsp90 inhibitor BJ-B11 exhibits potent antitumor activity via induction of cell cycle arrest, apoptosis and autophagy in Eca-109 human esophageal squamous carcinoma cells.
Liu KS; Zhang Y; Ding WC; Wang SX; Xiang YF; Yang P; Chen ZP; Zheng K; Liu Z; Xia M; Wang YF
Int J Oncol; 2012 Dec; 41(6):2276-84. PubMed ID: 23076967
[TBL] [Abstract][Full Text] [Related]
18. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
[TBL] [Abstract][Full Text] [Related]
19. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
